Ono-Nita SK - Search Results

1

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.

Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M. Kato J, et al. J Med Virol. 2002 Feb;66(2):187-99. doi: 10.1002/jmv.2129. J Med Virol. 2002. PMID: 11782927

2

Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Kato N, et al. J Virol. 1997 Nov;71(11):8856-9. doi: 10.1128/JVI.71.11.8856-8859.1997. J Virol. 1997. PMID: 9343247 Free PMC article.

3

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. Kato N, et al. Hepatology. 2000 Aug;32(2):405-12. doi: 10.1053/jhep.2000.9198. Hepatology. 2000. PMID: 10915750

4

Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Ono-Nita SK, Kato N, Shiratori Y, Carrilho FJ, Omata M. Ono-Nita SK, et al. Antimicrob Agents Chemother. 2002 Aug;46(8):2602-5. doi: 10.1128/AAC.46.8.2602-2605.2002. Antimicrob Agents Chemother. 2002. PMID: 12121939 Free PMC article.

5

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

6

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Ono-Nita SK, Kato N, Shiratori Y, Masaki T, Lan KH, Carrilho FJ, Omata M. Ono-Nita SK, et al. Hepatology. 1999 Mar;29(3):939-45. doi: 10.1002/hep.510290340. Hepatology. 1999. PMID: 10051501

7

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Carrilho FJ, Omata M. Ono-Nita SK, et al. J Clin Invest. 1999 Jun;103(12):1635-40. doi: 10.1172/JCI5882. J Clin Invest. 1999. PMID: 10377169 Free PMC article.

8

Poor association of TT virus viremia with hepatocellular carcinoma.

Yoshida H, Kato N, Shiratori Y, Lan KH, Ono-Nita SK, Feng Z, Shiina S, Omata M. Yoshida H, et al. Liver. 2000 Jun;20(3):247-52. doi: 10.1034/j.1600-0676.2000.020003247.x. Liver. 2000. PMID: 10902976

9

Large isoform of hepatitis delta antigen activates serum response factor-associated transcription.

Goto T, Kato N, Ono-Nita SK, Yoshida H, Otsuka M, Shiratori Y, Omata M. Goto T, et al. J Biol Chem. 2000 Dec 1;275(48):37311-6. doi: 10.1074/jbc.M002947200. J Biol Chem. 2000. PMID: 10961986 Free article.

10

Molecular aspects of hepatic carcinogenesis.

Nita ME, Alves VA, Carrilho FJ, Ono-Nita SK, Mello ES, Gama-Rodrigues JJ. Nita ME, et al. Rev Inst Med Trop Sao Paulo. 2002 Jan-Feb;44(1):39-48. doi: 10.1590/s0036-46652002000100007. Rev Inst Med Trop Sao Paulo. 2002. PMID: 11896411 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters